EYPT Butterfly Strategy
EYPT (EyePoint Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intravitreal implant for intravitreal injection for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye; and DEXYCU, a dexamethasone intraocular suspension, for the treatment of post-operative ocular inflammation, including treatment following cataract surgery. It is also developing EYP-1901, a twice-yearly bioerodible formulation of tyrosine kinase inhibitor for the treatment of wet age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion; and YUTIQ50 for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The company has strategic collaborations with Alimera Sciences, Inc., Bausch & Lomb, OncoSil Medical UK Limited, Ocumension Therapeutics, and Equinox Science, LLC. It also has a commercial alliance with ImprimisRx PA, Inc. for the joint promotion of DEXYCU for the treatment of post-operative inflammation following ocular surgery. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018.
EYPT (EyePoint Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.13B, a beta of 1.77 versus the broader market, a 52-week range of 5.35-19.11, average daily share volume of 1.3M, a public-listing history dating back to 2005, approximately 165 full-time employees. These structural characteristics shape how EYPT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.77 indicates EYPT has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a butterfly on EYPT?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current EYPT snapshot
As of May 15, 2026, spot at $12.46, ATM IV 69.60%, IV rank 8.17%, expected move 19.95%. The butterfly on EYPT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this butterfly structure on EYPT specifically: EYPT IV at 69.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a EYPT butterfly, with a market-implied 1-standard-deviation move of approximately 19.95% (roughly $2.49 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated EYPT expiries trade a higher absolute premium for lower per-day decay. Position sizing on EYPT should anchor to the underlying notional of $12.46 per share and to the trader's directional view on EYPT stock.
EYPT butterfly setup
The EYPT butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With EYPT near $12.46, the first option leg uses a $11.84 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed EYPT chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 EYPT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $11.84 | N/A |
| Sell 2 | Call | $12.46 | N/A |
| Buy 1 | Call | $13.08 | N/A |
EYPT butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
EYPT butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on EYPT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on EYPT
Butterflies on EYPT are pinning bets - traders use them when they expect EYPT to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
EYPT thesis for this butterfly
The market-implied 1-standard-deviation range for EYPT extends from approximately $9.97 on the downside to $14.95 on the upside. A EYPT long call butterfly is a pinning play: it pays maximum at the middle strike if EYPT settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current EYPT IV rank near 8.17% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on EYPT at 69.60%. As a Healthcare name, EYPT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to EYPT-specific events.
EYPT butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. EYPT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move EYPT alongside the broader basket even when EYPT-specific fundamentals are unchanged. Always rebuild the position from current EYPT chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on EYPT?
- A butterfly on EYPT is the butterfly strategy applied to EYPT (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With EYPT stock trading near $12.46, the strikes shown on this page are snapped to the nearest listed EYPT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are EYPT butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the EYPT butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 69.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a EYPT butterfly?
- The breakeven for the EYPT butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current EYPT market-implied 1-standard-deviation expected move is approximately 19.95%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on EYPT?
- Butterflies on EYPT are pinning bets - traders use them when they expect EYPT to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current EYPT implied volatility affect this butterfly?
- EYPT ATM IV is at 69.60% with IV rank near 8.17%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.